Nuvectis Pharma Inc • NVCT

Capital at risk.

About Nuvectis Pharma Inc
Ticker
info
NVCT
Trading on
info
NASDAQ
ISIN
info
US67080T1088
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Ron Bentsur M.B.A.
Headquarters
info
1 Bridge Plaza, Fort Lee, NJ, United States, 07024
Employees
info
13
Website
info
nuvectis.com
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trial for the treatment of patients with platinum-resistant ARID1a-mutated ovarian carcinoma. The company is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Metrics
BasicAdvanced
Market cap
info
$145M
P/E ratio
info
-
EPS
info
-$1.13
Dividend Yield
info
0.00%
Beta
info
-0.26
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$145M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
7.53
Earnings
EPS
info
-$1.13
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-0.26
52-week High
info
$11.80
52-week Low
info
$4.44
50-day moving average
info
$8.36
200-day moving average
info
$7.59
Short ratio
info
14.17
Short %
info
24.47%
Management effectiveness
ROE (TTM)
info
-115.29%
ROA (TTM)
info
-52.69%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
20.9M
Float
info
15M
Insiders %
info
46.91%
Institutions %
info
9.95%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$19.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.26
-$0.26
-0.77%
Q2 • 24Missed
-$0.24
-$0.25
4.00%
Q3 • 24Beat
-$0.35
-$0.26
-36.35%
Q4 • 24Missed
$0.27
-$0.26
203.85%
Q1 • 25Beat
-
-$0.25
100.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-6.2M
-∞%
Q4 • 24
$0M
$-5.3M
-∞%
Q1 • 25
NaN%
-14.66%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$18.6M
$8.9M
47.80%
Q4 • 24
$30.1M
$9.2M
30.50%
Q1 • 25
62.03%
3.37%
-36.20%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2.5M
$0M
$3.8M
$-2.5M
Q4 • 24
$-4.2M
$0M
$15.5M
$-4.2M
Q1 • 25
69.33%
-
304.94%
69.33%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Nuvectis Pharma Inc share?
Collapse

Nuvectis Pharma Inc shares are currently traded for undefined per share.

How many shares does Nuvectis Pharma Inc have?
Collapse

Nuvectis Pharma Inc currently has 20.9M shares.

Does Nuvectis Pharma Inc pay dividends?
Collapse

No, Nuvectis Pharma Inc doesn't pay dividends.

What is Nuvectis Pharma Inc 52 week high?
Collapse

Nuvectis Pharma Inc 52 week high is $11.80.

What is Nuvectis Pharma Inc 52 week low?
Collapse

Nuvectis Pharma Inc 52 week low is $4.44.

What is the 200-day moving average of Nuvectis Pharma Inc?
Collapse

Nuvectis Pharma Inc 200-day moving average is $7.59.

Who is Nuvectis Pharma Inc CEO?
Collapse

The CEO of Nuvectis Pharma Inc is Ron Bentsur M.B.A..

How many employees Nuvectis Pharma Inc has?
Collapse

Nuvectis Pharma Inc has 13 employees.

What is the market cap of Nuvectis Pharma Inc?
Collapse

The market cap of Nuvectis Pharma Inc is $145M.

What is the P/E of Nuvectis Pharma Inc?
Collapse

The current P/E of Nuvectis Pharma Inc is null.

What is the EPS of Nuvectis Pharma Inc?
Collapse

The EPS of Nuvectis Pharma Inc is -$1.13.

What is the PEG Ratio of Nuvectis Pharma Inc?
Collapse

The PEG Ratio of Nuvectis Pharma Inc is null.

What do analysts say about Nuvectis Pharma Inc?
Collapse

According to the analysts Nuvectis Pharma Inc is considered a buy.